SoylentNews is people
SoylentNews
The FDA is asking food makers and eating establishments to voluntarily reduce salt levels in their products to help reduce Americans' high salt intake.
The draft guidelines target these sources of salt with the goal of reducing Americans' average daily salt intake from 3,400 milligrams (mg) a day to 2,300 mg a day.
[...] Currently, 90 percent of American adults consume more salt than recommended, the FDA pointed out.
[...] The public has until the fall to comment on the FDA's voluntary salt guidelines for food manufacturers and restaurants.
The FDA claims that people can always add more salt to their food, which is true, but they ignore that salt changes how food is cooked and adding salt to the surface of food affects taste differently than when it is evenly distributed.
http://www.medicinenet.com/script/main/art.asp?articlekey=197193
https://en.wikipedia.org/wiki/Health_effects_of_salt
(Score: 0) by Anonymous Coward on Thursday July 28 2016, @03:09AM
pharmaceutical companies would rather have customers for life than actually cure the underlying pathology :(
You're wrong.
Pharma cares about money and any company that could produce a cure for hypertension would become so fucking rich that they wouldn't even know what to do with the money. They would own the market and have a very steady supply of patients.
(Score: 2) by Azuma Hazuki on Thursday July 28 2016, @03:23AM
I see people say this a lot, but I don't think reality would bear it out. Sure, they'd be rich...for a few quarters. Then no one would need their wonder drug any longer. What then, ese?
I am "that girl" your mother warned you about...
(Score: 0) by Anonymous Coward on Thursday July 28 2016, @11:06AM
Sure, they'd be rich...for a few quarters.
You expect that a company would sit on a cure so that they could continue making a small fraction of the profit while competing with many other companies?
This would require the company to be 100% sure no other company would beat them to market, hide the results of their clinical trial data, convince all of their employees that their family members and friends do not need the drug, and not value short-term profit and fame.
Heart disease is the leading cause of death in the world (and, importantly, that is also true for rich countries), so it is the largest market and new people are being made all the time.
The most likely course would start like the HCV cure: charge as much as the market will bear and negotiate generic licenses so people don't take over your manufacturing facilities or violate IP laws.
https://en.wikipedia.org/wiki/Sofosbuvir [wikipedia.org]